<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We determined the urate and <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> concentrations in the cerebrospinal fluid (CSF) in patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> of the <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e> type (VDBT), Alzheimer type <z:hpo ids='HP_0000726'>dementia</z:hpo> (ATD), and <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We found that the urate concentration was significantly increased in VDBT patients, but significantly decreased in ATD patients compared with controls </plain></SENT>
<SENT sid="2" pm="."><plain>The ratio of the concentrations of <z:chebi fb="3" ids="27226">uric acid</z:chebi> (UCSF) to <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> (XCSF) in the CSF (UCSF/XCSF) had a significant correlation with the ratio of the UCSF to the urate concentration in serum (U(serum)) (UCSF/U(serum)) in ATD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, whereas UCSF/U(serum) increased independently of UCSF/XCSF in VDBT </plain></SENT>
<SENT sid="3" pm="."><plain>We concluded that the significant increase in the urate concentration in VDBT is mainly due to an impairment of the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>), and its significant reduction in ATD may reflect impaired brain metabolism </plain></SENT>
</text></document>